Generate a tailored SOP for Dr. Jeremy Segal. Improve your application with a focused, well-structured draft.
Jeremy Segal is a Professor in the Department of Pathology at the University of Chicago. His clinical interests focus on Genomic Molecular Pathology, particularly in the development and validation of large-scale genomic assays and bioinformatics systems to support personalized oncology practices. He specializes in generation sequencing testing and patient management in oncology diagnosis. His research encompasses genomic analysis of tumors and the exploratory use of bioinformatics to enhance personalized cellular immunotherapy. He is the Director of Molecular Cytogenetic Pathology and has held the position of President of the Genomics Association Academic Laboratories. His work has contributed significantly to the understanding and treatment of various malignancies, including BAP1-Mutated Clear Cell Renal Cell Carcinoma and has been published in numerous peer-reviewed journals.
University of Chicago • Chicago, IL
Jeremy Segal serves as a Professor in the Department of Pathology.
Department of Philosophy